Table 3.
Plasma l-citrulline, l-arginine, ADMA, and SDMA levels in 16-week-old male offspring exposed to high-fat diet (HFD) and AICAR in pregnancy or lactation.
Groups | Control | HFD | AICAR/P | HFD + AICAR/L | HFD + AICAR/P |
---|---|---|---|---|---|
L-citrulline | 59.7 ± 4.5 | 53.7 ± 3.4 | 55.1 ± 4.6 | 57.1 ± 3.1 | 62.7 ± 3 |
L-arginine | 141.4 ± 6.2 | 104.6 ± 4.4 a | 171.2 ± 10.6 a | 115.5 ± 3.3 a | 140.2 ± 7.2 c |
ADMA | 1.35 ± 0.12 | 1.42 ± 0.09 | 1.73 ± 0.11 a | 1.53 ± 0.06 | 1.19 ± 0.07 |
SDMA | 0.57 ± 0.11 | 0.7 ± 0.03 | 0.7 ± 0.06 | 0.52 ± 0.02 b | 0.49 ± 0.05 c |
L-arginine-to-ADMA ratio | 110 ± 12 | 75 ± 3 a | 99 ± 3 | 76 ± 3 a | 118 ± 4 c |
ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; HFD, high-fat diet; AICAR/P, AICAR treatment during pregnancy; HFD + AICAR/L, high-fat diet plus AICAR treatment during lactation; HFD + AICAR/P, high-fat diet plus AICAR treatment during pregnancy; n = 7/group; a p < 0.05 vs. control; b p < 0.05 HFD vs. HFD + AICAR/L; c p < 0.05 HFD vs. HFD + AICAR/P.